Disease: B-cell lymphomas
- 18Beta-Glycyrrhetinic Acid Attenuates H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Damage and Apoptosis in Intestinal Epithelial Cells via Activating the PI3K/Akt Signaling Pathway
- A case of diffuse large B-cell lymphoma with decompensated alcohol-related liver cirrhosis treated successfully by chemoimmunotherapy
- A Case of Esophageal MALT Lymphoma Mimicking a Subepithelial Tumor
- A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis
- A case of primary central nervous system lymphoma of the sellar region presented with panhypopituitarism
- Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells
- Aminophylline Improves Ventilator-Induced Diaphragmatic Dysfunction by Targeting IGF-1-FOXO1-MURF1 Pathway
- Analgesic Mechanism of Dexmedetomidine and Esketamine in Rats with Spinal Cord Injury
- Angiostrongylus cantonensis induces energy imbalance and dyskinesia in mice by reducing the expression of melanin-concentrating hormone
- Arginine alleviates <em>Clostridium perfringens</em> α toxin-induced intestinal injury <em>in vivo</em> and <em>in vitro</em> via the SLC38A9/mTORC1 pathway
- Argon neuroprotection in ischemic stroke and its underlying mechanism
- Artemisinin Confers Cytoprotection toward Hydrogen Peroxide-Induced Cell Apoptosis in Retinal Pigment Epithelial Cells in Correlation with the Increased Acetylation of Histone H4 at Lysine 8
- Astaxanthin as an Anticancer Agent against Breast Cancer: An <em>In Vivo</em> and <em>In Vitro</em> Investigation
- B-cell lymphoma with intracellular crystals: a mimic of crystal-storing histiocytosis
- BCL9 is a Risk Factor of Neck Lymph Nodes Metastasis and Correlated with Immune Cell Infiltration in Papillary Thyroid Carcinoma
- BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation
- Bilateral Cytomegalovirus Retinitis After Chimeric Antigen Receptor T-cell Therapy for B-cell Lymphoma
- Biochemical, morphological and molecular assessments of n butanol fraction of Phoenix dactylifera L. following exposure to inorganic mercury on the liver of Wistar rats
- Breast mucosa-associated lymphoid tissue lymphoma: A case report and literature review
- Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis
- CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma
- Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma
- Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
- Clinical Features and Prognostic Analysis of Newly Diagnosed Diffuse Large B-cell Lymphoma Combined with Hemophagocytic Syndrome
- Combination of Tractography, Intraoperative Computed Tomography and 5-Aminolevulinic Acid Fluorescence in Stereotactic Brain Biopsies: A Case Series
- Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center
- Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
- Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and Prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma
- Curcumin Combined with Thalidomide Inhibits Proliferation of KG-1 Cells and Its Related Mechanisms
- Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes
- Decoding the impact of primary cutaneous B-cell lymphomas on patients' well-being
- Defining Primary Refractory Large B-cell Lymphoma
- Discovery of novel pyridone-benzamide derivatives possessing a 1-methyl-2-benzimidazolinone moiety as potent EZH2 inhibitors for the treatment of B-cell lymphomas
- Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications
- Don't keep me waiting: estimating the lifetime impact of reduced vein-to-vein time for CAR-T treated patients with LBCL
- Effect and mechanisms of Gambi-jung against high-fat diet-induced cardiac apoptosis in mice
- Effects of Cannabidiol, 9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines
- Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel
- Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma
- Electroacupuncture at the Dazhui and Baihui acupoints and different frequencies (10 and 50 Hz) protects against apoptosis by up-regulating ERK1/2-mediated signaling in rats after global cerebral ischemia
- Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis
- Epstein-Barr-Virus-Related Lymphoproliferative Disorder in a Patient With Primary Myelofibrosis: A Case Report and Literature Review
- Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report
- Expression of CD30 in Patients with Diffuse Large B-Cell Lymphoma and Clinical Significance
- First Use of Upfront Polatuzumab Vedotin in Post-transplant Lymphoproliferative Disorder: A Case Report
- Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol
- FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia
- Glutamate rescues heat stress-induced apoptosis of Sertoli cells by enhancing the activity of antioxidant enzymes and activating the Trx1-Akt pathway in vitro
- Hepatic Tumor Rupture in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders of the B-cell Type in a Patient With Chronic Rheumatoid Arthritis
- Hsa_circ_0087862 contributes to the progression of colorectal cancer through regulating miR-512-3p/HK2 axis
- Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas
- Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example
- Immunotherapy of Hematological Malignancies of Human B-Cell Origin with CD19 CAR T Lymphocytes
- Impact of carbimazole combined with vitamin E on testicular injury induced by experimental hyperthyroidism in adult albino rats: oxidative/inflammatory/apoptotic pathways
- In Vitro Inhibition of Colorectal Cancer Gene Targets by <em>Withania somnifera</em> L. Methanolic Extracts: A Focus on Specific Genome Regulation
- In Vivo Mapping of Myocardial Injury Outside the Infarct Zone: Tissue at an Intermediate Pathological State
- Investigating the safety and feasibility of osteopathic manipulative medicine in hospitalized children and adolescent young adults with cancer
- LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function
- Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferation
- Long-term remission after upfront autologous hematopoietic stem cell transplant for CD5(+) diffuse large-B cell lymphoma
- Mitochondrial-dependent oxidative phosphorylation is key for postnatal metabolic adaptation of alveolar macrophages in the lung
- Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia
- NCI 159456 PERK Inhibitor as a Targeted Therapy for Lung Cancer: An In Vitro Study
- Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studies
- New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naive resistance to pan-HDA
- New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group
- Nonbacterial thrombotic endocarditis of mitral valve associated with a lymphoproliferative malignancy: case report and literature review
- Ophthalmic Manifestations in Patients with Blood Malignancies
- Paediatric cutaneous lymphomas including rare subtypes: A 40-year experience at a tertiary referral centre
- Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis
- PDX Models in Theranostic Applications: Generation and Screening for B Cell Lymphoma of Human Origin
- Pegylated-liposomes increase the efficacy of Idelalisib in lymphoma B-cells
- Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects
- Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence
- Preventive effect of free radical scavenger edaravone lotion on cyclophosphamide chemotherapy-induced alopecia
- Primary Extranodal Diffuse Large B-cell Lymphoma Presenting in the Lips: A Case Report and Literature Review
- Real-world CAR-T findings for large B-cell lymphoma from a single institution experience
- Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by 18F-FDG PET/CT and Biopsy: A Diagnostic Challenge
- Research Progress of Targeted Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma --Review
- Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt Lymphoma RAJI Cell Line
- Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque
- Ruptured Baker Cyst on 18F-FDG PET/CT
- Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma
- Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma
- Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma
- SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
- Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database
- Supportive care measures for bispecific T-cell engager therapies in haematological malignancies
- Tanshinone IIA improves Alzheimer's disease <em>via</em> RNA nuclear-enriched abundant transcript 1/microRNA-291a-3p/member RAS oncogene family Rab22a axis
- Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis
- Targets and treatments in primary CNS lymphoma
- Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies a high risk subgroup with inferior survival
- The Value of Baseline PET/CT Imaging of Bone Marrow <sup>18</sup>F-FDG Uptake Pattern in Predicting Prognosis of DLBCL
- TRAF3 loss-of-function reveals the noncanonical NF-kappaB pathway as a therapeutic target in diffuse large B cell lymphoma
- Treatment of Catheter-Associated Internal Jugular Vein Thrombosis Using Apixaban for Less Than Three Months in Two Patients With Aggressive B-cell Lymphoma Undergoing Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy
- Treatment of relapsed/refractory chronic lymphocytic leukemia with Zanubrutinib after progressing on other BTK inhibitors
- Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma
- TYM-3-98, a novel selective inhibitor of PI3Kdelta, demonstrates promising preclinical antitumor activity in B-cell lymphomas
- Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management
- XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways